top of page
Moving People

News

German officials back AstraZeneca vaccine after clot concerns

  • Reuters
  • Mar 12, 2021
  • 1 min read


Top German public health officials said AstraZeneca’s Covid-19 vaccine was safe and Germany would continue to use it today after several European countries halted its distribution amid safety concerns.


Health authorities in Denmark, Norway and Iceland yesterday suspended the use of AstraZeneca’s vaccine after reports of blood clots in some people who had been vaccinated.


With Germany still facing a scarcity of vaccines and a third wave of Covid-19, the government is anxious to ensure that vaccine scepticism does not undermine the roll-out on which it is banking to bring the pandemic under control.


“Everything we know so far suggests that the benefits of the vaccine, even after every individual case reported, are greater than the risks, and that continues to be the case,” Health Minister Jens Spahn told a news briefing.


Lothar Wieler, head of the Robert Koch Institute for Infectious Diseases, added that there was no statistical evidence of excess mortality after any coronavirus shot.


“Since we’re now vaccinating the old and very old, and most people who die are of course old and very old, then there can be a chronological link between vaccination and death,” he said.


“There is no evidence that the link is statistically excessive,” Wieler added.


The number of confirmed coronavirus cases in Germany rose by 12,834 to 2,545,781, the RKI said, indicating it was now at the start of a third wave and Spahn warned hard weeks were to come.


Flagging vaccine deliveries are slowing the roll-out, with Spahn describing as “unsatisfactory” reports that deliveries of AstraZeneca’s and Moderna’s vaccines could be volatile.


“We are still in a phase of absolute scarcity,” he said.

Comments


construction-image1.jpg

Subscribe and keep up to date with all the latest news from Oakmark

Subtle Shapes Transparent
WEST AFRICA'S NO.1 ECONOMIC AGENTS

Oakmark Global Vision provides a bespoke business package to established corporate bodies, investors, and entrepreneurs who desire to enter the West & Pan African market. Find out more >

© 2025 Oakmark Global Vision Ltd - All Rights Reserved.

UK Company No. 07634879 / Nigeria Company No. RC 1288232

Regional Office

International Office

1 Kandi Close, Off Aminu Kano

Crescent, Wuse 2, Abuja F.C.T

Nigeria 

+234 -(0)- 929 207 02

+234 (0) 704 497 6500

info@oakmarkglobalvision.com

King Court, 17 School Road

Hall Green, Birmingham

United Kingdom  B28, 8JG

+44 (0) 121 244 1814

+44 (0) 746 625 2505

info@oakmarkglobalvision.com

 Oakmark Global Vision Limited

bottom of page